Substituted indoline derivatives as dengue viral replication inhibitors
US10913716B2 · kind B2 · utility
0Cited by
14References
16Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Mar 31, 2017 |
| Grant date | Feb 9, 2021 |
| Priority date | — |
| Expiry date | Jan 8, 2038 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention concerns substituted indoline compounds, methods to prevent or treat dengue viral infections by using said compounds and also relates to said compounds for use as a medicine, more preferably for use as a medicine to treat or prevent dengue viral infections. The present invention furthermore relates to pharmaceutical compositions or combination preparations of the compounds, to the compositions or preparations for use as a medicine, more preferably for the prevention or treatment of dengue viral infections. The invention also relates to processes for preparation of the compounds.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.